Spinal Tech

Zacks downgraded RTI Surgical from a "hold" rating to a "sell" rating, according to MidSouth News & Analysis.

Bioventus is entering the patient care market in Taiwan with the launch of DUROLANE.

There has been an upsurge in global demand for orthopedic biomaterials, according to a new report by Research and Markets.

Cardinal Spine filed a form D announcing $1.25 million in equity financing, according to an OctaFinance report.

Nashville, Tenn.-based Vanderbilt University researchers discovered fibrin is not crucial for bone fracture healing, contrary to popular belief. Rather, fibrin's breakdown and clearance are important to the healing process, according to MD News.

San Antonio-based Premier Pain Consultants is offering radiofrequency ablation for patients with chronic knee pain.

Researchers at the University of New South Wales in Australia are developing and testing the Thru-Fuze device to promote bone growth during spinal fusion, according to a HospiMedica report.

Zacks upgraded Exactech from a "sell" rating to a "strong buy" rating, according to a Dakota Financial News report.

Orchid Orthopedic Solutions has completed its acquisition of the Cam Bioceramics' coating facility and operations in China.

Here are 13 key notes on orthopedic and spine device companies over the past week.